CW
GILD icon

Cabot-Wellington’s Gilead Sciences GILD Stock Holding History

Cabot-Wellington’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,175
Closed -$82K – 14
2021
Q3 		$82K Hold
1,175
– – 0.04% 15
2021
Q2 		$81K Hold
1,175
– – 0.04% 15
2021
Q1 		$76K Hold
1,175
– – 0.04% 15
2020
Q4 		$68K Buy
+1,175
New +$70.9K 0.03% 15
2018
Q1 		– Sell
-137,230
Closed -$9.83M – 11
2017
Q4 		$9.83M Sell
137,230
-5,760
-4% -$437K 5.98% 6
2017
Q3 		$11.6M Hold
142,990
– – 6.73% 6
2017
Q2 		$10.5M Sell
142,990
-3,500
-2% -$233K 6.03% 6
2017
Q1 		$9.66M Hold
146,490
– – 5.73% 8
2016
Q4 		$10.5M Sell
146,490
-640
-0.4% -$47.6K 7.74% 5
2016
Q3 		$11.6M Sell
147,130
-773
-0.5% -$62.8K 9.41% 4
2016
Q2 		$11.8M Sell
147,903
-5,100
-3% -$453K 10.26% 3
2016
Q1 		$14.1M Sell
153,003
-400
-0.3% -$36.1K 10.36% 3
2015
Q4 		$15.5M Hold
153,403
– – 10.55% 3
2015
Q3 		$15.1M Sell
153,403
-1,200
-0.8% -$133K 9.06% 2
2015
Q2 		$18.1M Sell
154,603
-2,275
-1% -$249K 8.92% 2
2015
Q1 		$15.4M Sell
156,878
-3,559
-2% -$361K 6.54% 3
2014
Q4 		$15.1M Sell
160,437
-14,225
-8% -$1.47M 5.62% 3
2014
Q3 		$18.6M Sell
174,662
-5,610
-3% -$549K 6.9% 3
2014
Q2 		$14.9M Sell
180,272
-5,410
-3% -$421K 5.29% 4
2014
Q1 		$13.2M Sell
185,682
-35,020
-16% -$2.75M 4.91% 6
2013
Q4 		$16.6M Sell
220,702
-10,983
-5% -$765K 6.09% 3
2013
Q3 		$14.6M Sell
231,685
-28,755
-11% -$1.72M 5.71% 4
2013
Q2 		$13.4M Buy
+260,440
New +$13.6M 5.61% 4

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cabot-Wellington's GILD Position: Q4 2021 in Review

Cabot-Wellington sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 1,175 shares — an estimated $82K sold.

Cabot-Wellington first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $18.6M in Q3 2014. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Cabot-Wellington reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Cabot-Wellington sold 1,175 Gilead Sciences shares in Q4 2021, an estimated $82K.
  • Cabot-Wellington first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Cabot-Wellington's Gilead Sciences position peaked at $18.6M in Q3 2014.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Cabot-Wellington's 13F filing for Q4 2021, filed 21 Mar 2023.